LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Clinical Laboratory Diagnostics Tool Targeted Towards Addiction

By LabMedica International staff writers
Posted on 30 Jun 2010
A privately held clinical urine drug-testing laboratory offers a reporting service that provides clinicians with accurate testing results and analytical feedback to augment the assessment and monitoring of an individual's drug use upon admission and throughout the course of addiction treatment.

The new Comprehensive Analysis of Reported Drugs (CARD) reporting service was developed to create a highly personalized clinical report by correlating an individual's prescribed medication use and self-reported drug misuse with its state-of-the-art diagnostic testing.

Dominion Diagnostics (North Kingstown, RI, USA) performs all the necessary testing at its laboratory and turns around testing results to clients through a number of different formats. The initial results are deliverable 24 hours from receipt of the specimen in the laboratory, with confirmatory results by alternate method available within a few days. Dominion works with a variety of medical specialties, but the new CARD report is in fact targeted towards addiction treatment and behavioral health.

CARD utilizes laboratory results from validated quantitative urine drug testing profiles for commonly abused illicit and prescription drugs and/or their metabolites, as well as biological markers and commercial adulterant screening (i.e., creatinine, specific gravity, pH, and oxidants) to ensure specimen validity.

The results provide data to support and measure a treatment program's ability to reduce morbidity in substance abuse, improve retention in treatment, and promote the use of evidence-based practice for individuals suffering from addiction and mental health disorders, in line with ongoing initiatives supported by the Substance Abuse and Mental Health Services Agency (SAMHSA; Rockville, MD, USA).

Dominion Diagnostics is a premier provider of comprehensive clinical quantitative urine drug testing, medication monitoring, and support services nationwide.

Related Links:
Dominion Diagnostics
Substance Abuse and Mental Health Services Agency



New
Gold Member
Automatic Hematology Analyzer
CF9600
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Clinical Informatics Platform
CLARION™
New
All-in-One Molecular System
AIO M160

Latest Clinical Chem. News

Automated NfL Assay Supports Monitoring of Neurological Disorders
30 Jun 2010  |   Clinical Chem.

Blood-Based Screening Test Targets Early Detection of Colorectal Cancer
30 Jun 2010  |   Clinical Chem.

New CLIA Status Brings Mass Spectrometry Steroid Testing to Routine Labs
30 Jun 2010  |   Clinical Chem.



INTEGRA BIOSCIENCES AG